| MAGN |
Magnera Corp |
Common Stock, $0.01 par value per share (the "Common Stock") |
8% |
$33,194,333 |
|
2,832,281 |
|
Madison Avenue Partners, LP |
30 Sep 2025 |
| MDRX |
Veradigm Inc. |
Common Stock, par value $0.01 per share (the "Common Stock") |
6.6% |
$34,185,621 |
|
7,167,999 |
|
Madison Avenue International LP |
22 Jan 2026 |
| KROS |
Keros Therapeutics, Inc. |
Common Stock, $0.0001 par value per share (the "Common Stock") |
6.4% |
$32,000,280 |
|
2,614,402 |
|
Madison Avenue Partners, LP |
07 May 2025 |
| INDV |
Indivior PLC |
Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") |
6% |
$66,497,088 |
|
7,438,153 |
|
Madison Avenue International LP |
11 Mar 2025 |
| SLRN |
ACELYRIN, Inc. |
Common Stock |
5.1% |
$11,349,050 |
|
5,089,260 |
|
Madison Avenue Partners, LP |
29 Apr 2025 |
| WLY |
John Wiley & Sons, Inc. |
Class A Common Stock, par value $1.00 per share (the "Common Stock") |
5% |
$92,474,119 |
|
2,229,904 |
|
Madison Avenue Partners, LP |
31 Dec 2024 |
| OVID |
Ovid Therapeutics Inc. |
Common Stock, par value $0.001 per share (the "Common Stock") |
4% |
$889,649 |
|
2,852,352 |
|
Madison Avenue Partners, LP |
31 Dec 2024 |
| CRGX |
CARGO Therapeutics, Inc. |
Common stock, par value $0.001 per share (the "Common Stock") |
0% |
$0 |
-$18,745,508 |
0 |
-100% |
Madison Avenue Partners, LP |
30 Sep 2025 |
| SAGE |
Sage Therapeutics, Inc. |
Common Stock, par value $0.0001 per share (the "Common Stock") |
0% |
$0 |
-$52,748,924 |
0 |
-100% |
Madison Avenue Partners, LP |
30 Sep 2025 |